Increased high molecular weight fibrinogen in pre-eclampsia

Thrombosis Research

Volumn 111, Issue 3, 2003, Pages 143-147

  Manten, G T R ^a   Sikkema, J M ^a   Franx, A ^a   Hameeteman, T M ^a   Visser, G H A ^a   De Groot, P G ^a   Voorbij, H A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Coagulation; Fibrinogen; High molecular weight fibrinogen; Pre eclampsia; Pregnancy

Indexed keywords

FIBRINOGEN; LOW MOLECULAR WEIGHT KININOGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN LOCALIZATION; UPREGULATION;

EID: 0347480433     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.08.025     Document Type: Article

References (26)

1. Doolittle R.F. Fibrinogen and fibrin. Sci. Am. 245:1981;92-101.
2. Galanakis D.K., Mosesson M.W. Human fibrinogen heterogeneities: determination of the major Aα chain derivates in blood. Thromb. Res. 31:1983;403-413.
3. Nakashima A., Sasaki S., Miyazaki K., Miyata T., Iwanaga S. Human fibrinogen heterogeneity: the COOH-terminal residues of defective Aα chains of fibrinogen II. Blood Coagul. Fibrinolysis. 3:1992;361-370.
4. Holm B., Godal H.C. Quantitation of the three normally occurring plasma fibrinogens in health and during so called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma. Thromb. Res. 35:1984;279-290.
5. Holm B., Nilsen D.W.T., Kierulf P., Godal H.C. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb. Res. 37:1985;165-176.
6. Nieuwenhuizen W. Biochemistry and measurement of fibrinogen. Eur. Heart J. 16(SA):1995;6-10.
7. Holm B., Nilsen D.W.T., Godal H.C. Evidence that low molecular fibrinogen (LMW) is formed in man by degradation of high molecular weight fibrinogen (HMW). Thromb. Res. 41:1986;879-884.
8. Jensen T., Halvorsen S., Godal H.C., Sandset P.M., Skjønsberg O.H. Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction. Thromb. Res. 100:2000;397-403.
9. Holm B., Brosstad F., Kierulf P., Godal H.C. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the a-chain is of importance for the fibrin polymerization. Thromb. Res. 39:1985;595-606.
10. Redman C.W.G., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180:1999;499-506.
11. Roberts J.M., Redman C.W.G. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 341:1993;1447-1451.
12. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204.
13. Kjellberg U., Andersson N.E., Rosén S., Tengborn L., Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb. Haemost. 81:1999;527-531.
14. Stirling Y., Woolf L., North W.R.S., Seghatchian M.J., Meade T.W. Haemostasis in normal pregnancy. Thromb. Haemost. 52:1984;176-182.
15. McKay D.G. Chronic intravascular coagulation in normal pregnancy and preeclampsia. Contrib. Nephrol. 25:1981;108-119.
16. Kanfer A., Bruch J.F., Nguyen G., He C.J., Delarue F., Flahault A.et al. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab. Invest. 74:1996;253-258.
17. Maki M. Coagulation, fibrinolysis, platelet and kinin forming systems during toxemia of pregnancy. Biol. Res. Pregnancy. 4:1983;152-154.
18. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:1988;892-898.
19. Sibai B.M., Taslimi M.M., El-Nazer A., Amon E., Mabie B.C., Ryan G.M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 155:1986;501-509.
20. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 17:1957;237-246.
21. Vila V., Reganon E., Llopis F., Aznar J. A rapid method for isolation of fibrinogen from human plasma by precipitation with polyethylene glycol 6000. Thromb. Res. 39:1985;651-656.
22. Adler G., Duchinski T., Jasinska A., Piotrowska U. Fibrinogen fractions in the third trimester of pregnancy and in puerperium. Thromb. Res. 97:2000;405-410.
23. Meade T.W., Brozovic M., Chakrabarti R., Howarth D.J., North W.R.S., Stirling Y. An epidemiological study of the haemostatic and other effects of oral contraceptives. Br. J. Haematol. 34:1976;353-364.
24. Weitz J.I., Landman S.L., Crowley K.A., Birken S., Morgan F.J. Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency. J. Clin. Invest. 78:1986;155-162.
25. He S., Silveira A., Hamsten A., Blombäck M., Bremme K. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb. Haemost. 81:1999;538-542.
26. Lip G.Y.H., Edmunds E., Hee F.L.L.S., Blann A.D., Beevers D.G. A cross-sectional, diurnal, and follow up study of platelet activation and endothelial dysfunction in malignant phase hypertension. Am. J. Hypertens. 14:2001;823-828.